Dr Amina Chaouch
Clinical Research Associate
Email: amina.chaouch@ncl.ac.uk Address: Institute of Human Genetics
Newcastle University
International Centre for Life
Central Parkway
Newcastle upon Tyne
NE1 3BZ
United Kingdom
Chaouch A, Muller JS, Guergueltcheva V, Dusl M, Schara U, Rakocevic-Stojanovic V, Lindberg C, Scola RH, Werneck LC, Colomer J, Nascimento A, Vilchez JJ, Muelas N, Argov Z, Abicht A, Lochmuller H. A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome .
Journal of Neurology 2012, 259 (3), 474-481.
Straub V, Aartsma-Rus A, Szigyarto CAK, Beroud C, Bonaldo P, Borgiani P, Braghetta P, Chaouch A, Cirak S, Courtot L, Daraselia N, Gelfi C, 't Hoen PAC, Kotelnikova E, Le Priol Y, Lochmueller H, Morgan J, Muntoni F, Novelli G, Paolillo N, Tanzi R, Turner C, Uhlen M, Ferlini A. BIO-NMD: Discovery and validation of biomarkers for neuromuscular diseases (NMDs) - An EU funded FP7 project .
In: 16th International Congress of The World Muscle Society . 2011, Almancil, Algarve, Portugal: Elsevier.
Barisic N, Chaouch A, Muller JS, Lochmuller H. Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes .
European Journal of Paediatric Neurology 2011, 15 (3), 189-196.
Martin FC, Oonk S, 't Hoen PAC, Nadarajah VD, Chaouch A, Lochmuller H, Dalebout H, van der Burgt YEM, Palmblad M, Deelder AM. Mass spectrometry based clinical proteomics for biomarker discovery in Duchenne muscular dystrophy .
In: Neuromuscular Disorders: 16th International Congress of the World Muscle Society . 2011, Algarve, Portugal: Elsevier Ltd.
Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Lochmuller H, Ginjaar HB, Aartsma-Rus AM, van Ommen GJB, den Dunnen JT, 't Hoen PAC. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD) .
Neuromuscular Disorders 2011, 21 (8), 569-578.
't Hoen PAC, Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, Ginjaar HB, Aartsma-Rus AM, van Ommen GJB, den Dunnen JT, Lochmuller H. Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring Duchenne muscular dystrophy (DMD) disease progression .
In: Neuromuscular Disorders: 16th International Congress of the World Muscle Society . 2011, Algarve, Portugal: Elsevier Ltd.